Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Study product A (Wonderlab wonder4shape)
Chongqing Precision Biotech Co., Ltd
Overweight and Obesity
1 trial -
Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval
Biotech Pharmaceutical Co.,
Diphtheria
1 trial -
Sulfadoxine-pyrimethamine
United Therapeutics Europe Ltd
Anaemia
1 trial -
Super Cereal Plus (SC+)
United Therapeutics Europe Ltd
Moderate Acute Malnutrition (MAM)
1 trial -
Supplementary Food
United Therapeutics Europe Ltd
Moderate Acute Malnutrition
1 trial -
Surgery combined with Target-reduction intensity-modulated radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
Synbiotic
United Therapeutics Europe Ltd
Non-Alcoholic Fatty Liver Disease
1 trial -
TCM+ Routine Therapy
The First People's Hospital of Lianyungang
Proteinuria
1 trial -
TEA plus GDMT
The First People's Hospital of Lianyungang
Heart Failure With Reduced Ejection Fraction
1 trial -
TNK plus standard medical treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Ischemic Stroke
1 trial -
TRF (Tocotrienol-rich-fraction)
United Therapeutics Europe Ltd
End Stage Renal Disease
1 trial -
TRT
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Tacrolimus+Mycophenolate mofetil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lupus Nephritis
1 trial -
Tadalafil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pulmonary Arterial Hypertension (PAH)
1 trial -
Tafolecimab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Coronary Syndrome
1 trial -
Tailored AI echocardiogram analysis and reporting system
Hospital Authority, Hong Kong
Heart Failure
1 trial -
Targeted Amino Acid Supplement
United Therapeutics Europe Ltd
Parkinson Disease (PD)
1 trial -
Technochrom C1-INH Kit
Takeda
Hereditary Angioedema (HAE)
1 trial -
Tegoprazan-amoxicillin dual therapy
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
Telbivudine
Chinese University of Hong Kong
Chronic Hepatitis B
1 trial -
Telmisartan
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension
1 trial -
Tenofovir Disoproxil Fumarate
The First People's Hospital of Lianyungang
Hepatitis B, Chronic
1 trial -
Terbutaline
Hospital Authority, Hong Kong
Nonreassuring Fetal Status
1 trial -
Terlipressin
Sun Yat-sen University
Septic Shock
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources